MedPath

扬州一洋制药有限公司

Ownership
-
Established
2002-02-10
Employees
-
Market Cap
-
Website
www.yzilyang.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

NMPA:9

Drug Approvals

Dihydroergotoxine Methanesulfonate Tablets

Product Name
甲磺酸二氢麦角碱片
Approval Number
国药准字H20113450
Approval Date
Apr 21, 2021
NMPA

Ibuprofen Suspension

Product Name
布洛芬混悬液
Approval Number
国药准字H20103544
Approval Date
Apr 8, 2020
NMPA

Gliclazide Tablets(Ⅱ)

Product Name
格列齐特片(Ⅱ)
Approval Number
国药准字H20023082
Approval Date
Apr 8, 2020
NMPA

Compound Azintamide Enteric-coated Tablets

Product Name
泌特
Approval Number
国药准字H20000232
Approval Date
Apr 8, 2020
NMPA

Lysine Acetylsalicylate for Injection

Product Name
注射用赖氨匹林
Approval Number
国药准字H10983009
Approval Date
Apr 8, 2020
NMPA

Lysine Acetylsalicylate for Injection

Product Name
注射用赖氨匹林
Approval Number
国药准字H20013011
Approval Date
Apr 8, 2020
NMPA

Almagate Suspension

Product Name
安达
Approval Number
国药准字H10980322
Approval Date
Apr 8, 2020
NMPA

Lysine Acetylsalicylate for Injection

Product Name
注射用赖氨匹林
Approval Number
国药准字H20013012
Approval Date
Apr 8, 2020
NMPA

Terazosin Hydrochloride Tablets

Product Name
盐酸特拉唑嗪片
Approval Number
国药准字H20093960
Approval Date
Jun 19, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.